$1.62
+0 (+0%)
At Close: Jan 16, 2026
IPA Increases Previously Announced Bought Deal Offering of Common Shares to $21.7 Million
10:50pm, Wednesday, 03'rd Feb 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody d
IPA Announces $10.0 Million Bought Deal Offering of Common Shares
05:55pm, Wednesday, 03'rd Feb 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody d
Sign In
Buy IPA